Close
View All Publications - Gail Tomlinson, MD, PhD
CPRIT grant to support HPV vaccination of childhood cancer survivors
A grant of nearly $1 million from the Cancer Prevention and Research Institute of Texas to The University of Texas Health Science Center at San Antonio (UT Health San Antonio) will expand a program of vaccination for human papillomavirus (HPV) among survivors of childhood cancer. HPV is the most common sexually transmitted infection, but […]
A Phase II multicenter, open-label, single-arm dose escalation study of Asciminib monotherapy in 2nd and 1st Line Chronic Phase – Chronic Myelogenous Leukemia (ASC2ESCALATE) (CTMS# 23-0101)
This will be a multicenter Phase II open-label study of asciminib in CML-CP patients who have been previously treated with one prior ATP-binding site TKI with discontinuation due to treatment failure, warning, or intolerance. (2L patient cohort). In addition, newly diagnosed CML-CP patients who may have received up to 4 weeks of prior TKI are included in a separate 1L patient cohort.
Mays Cancer Center partners with American Cancer Society to increase lung cancer screenings in South Texas
Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, is partnering with the American Cancer Society to spread awareness and encourage more at-risk South Texans to screen for lung cancer.
Concentrated approach in chemotherapy comes to Mays Cancer Center, gives hope to patients with inoperable liver tumors
Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, proudly announces the launch of a specialized chemotherapy delivery system called hepatic artery infusion, also known as HAI pump therapy, for colorectal cancer patients whose tumors are inoperable and have spread to the liver. Approved by the US Food and Drug […]